Metsera
Reducing the burden of obesity
General Information
BounceWatch is an independent company data service, not affiliated with Metsera. To contact Metsera, visit metsera.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Metsera compare?
A PDF of Metsera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Metsera soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About Metsera
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Corporate | $10.00B | - |
|
04 Aug 2026 |
| Acquisition | $4.90B | 1 |
Pfizer
|
01 Sep 2025 |
| Series B | $275.00M | - |
|
01 Jan 2025 |
| Early VC | $290.00M | 7 |
|
01 Apr 2024 |
Latest News
View All
FAQ About Metsera
Source: BounceWatch company record for Metsera, https://bouncewatch.com/company/metsera, updated 4 August 2026. When citing, please name BounceWatch and link this page.
